139 related articles for article (PubMed ID: 37610042)
1. Disparities in treatment and survival in early-stage hepatocellular carcinoma in California.
Gholami S; Kleber KT; Perry LM; Abidalhassan M; McFadden NR; Bateni SB; Maguire FB; Stewart SL; Morris C; Chen M; Gaskill CE; Merkow RP; Keegan TH
J Surg Oncol; 2023 Dec; 128(8):1302-1311. PubMed ID: 37610042
[TBL] [Abstract][Full Text] [Related]
2. Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma.
Rich NE; Hester C; Odewole M; Murphy CC; Parikh ND; Marrero JA; Yopp AC; Singal AG
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):551-559.e1. PubMed ID: 29859983
[TBL] [Abstract][Full Text] [Related]
3. Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988-2012.
Stewart SL; Kwong SL; Bowlus CL; Nguyen TT; Maxwell AE; Bastani R; Chak EW; Chen MS
World J Gastroenterol; 2016 Oct; 22(38):8584-8595. PubMed ID: 27784971
[TBL] [Abstract][Full Text] [Related]
4. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
[TBL] [Abstract][Full Text] [Related]
5. Racial and insurance disparities in the receipt of transplant among patients with hepatocellular carcinoma.
Yu JC; Neugut AI; Wang S; Jacobson JS; Ferrante L; Khungar V; Lim E; Hershman DL; Brown RS; Siegel AB
Cancer; 2010 Apr; 116(7):1801-9. PubMed ID: 20143441
[TBL] [Abstract][Full Text] [Related]
6. Racial, Ethnic, and Socioeconomic Disparities in Curative Treatment Receipt and Survival in Hepatocellular Carcinoma.
Wagle NS; Park S; Washburn D; Ohsfeldt RL; Rich NE; Singal AG; Kum HC
Hepatol Commun; 2022 May; 6(5):1186-1197. PubMed ID: 34796703
[TBL] [Abstract][Full Text] [Related]
7. Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment.
Kaspers M; Llamocca E; Quick A; Dholakia J; Salani R; Felix AS
Am J Obstet Gynecol; 2020 Sep; 223(3):398.e1-398.e18. PubMed ID: 32142825
[TBL] [Abstract][Full Text] [Related]
8. Association of socioeconomics, surgical therapy, and survival of early stage hepatocellular carcinoma.
Peters NA; Javed AA; He J; Wolfgang CL; Weiss MJ
J Surg Res; 2017 Apr; 210():253-260. PubMed ID: 28457336
[TBL] [Abstract][Full Text] [Related]
9. Predictors of surgical intervention for hepatocellular carcinoma: race, socioeconomic status, and hospital type.
Zak Y; Rhoads KF; Visser BC
Arch Surg; 2011 Jul; 146(7):778-84. PubMed ID: 21422327
[TBL] [Abstract][Full Text] [Related]
10. Association Between Race/Ethnicity and Insurance Status with Outcomes in Patients with Hepatocellular Carcinoma.
Scaglione S; Adams W; Caines A; Devlin P; Mittal S; Singal AG; Parikh ND
Dig Dis Sci; 2020 Jun; 65(6):1669-1678. PubMed ID: 31643036
[TBL] [Abstract][Full Text] [Related]
11. Association of County-Level Upward Economic Mobility with Stage at Diagnosis and Receipt of Curative-Intent Treatment among Patients with Hepatocellular Carcinoma.
Paro A; Dalmacy D; Tslimigras DI; Cloyd J; Ejaz A; Pawlik TM
Ann Surg Oncol; 2022 Aug; 29(8):5177-5185. PubMed ID: 35441305
[TBL] [Abstract][Full Text] [Related]
12. Disparities in the Receipt of Recommended Curative Treatment for Patients with Early-Stage Hepatocellular Carcinoma.
Rasic G; de Geus SWL; Papageorge MV; Woods AP; Ng SC; McAneny D; Tseng JF; Sachs TE
World J Surg; 2023 Jul; 47(7):1780-1789. PubMed ID: 36918443
[TBL] [Abstract][Full Text] [Related]
13. Medicaid and Uninsured Hepatocellular Carcinoma Patients Have More Advanced Tumor Stage and Are Less Likely to Receive Treatment.
Wang J; Ha J; Lopez A; Bhuket T; Liu B; Wong RJ
J Clin Gastroenterol; 2018; 52(5):437-443. PubMed ID: 28723861
[TBL] [Abstract][Full Text] [Related]
14. Racial and Ethnic Disparities in Hepatocellular Carcinoma Treatment Receipt in the United States: A Systematic Review and Meta-Analysis.
Wagle NS; Park S; Washburn D; Ohsfeldt R; Kum HC; Singal AG
Cancer Epidemiol Biomarkers Prev; 2024 Apr; 33(4):463-470. PubMed ID: 38252039
[TBL] [Abstract][Full Text] [Related]
15. Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies.
Ha J; Yan M; Aguilar M; Tana M; Liu B; Frenette CT; Bhuket T; Wong RJ
J Clin Gastroenterol; 2016; 50(5):423-30. PubMed ID: 26583267
[TBL] [Abstract][Full Text] [Related]
16. Predictors of five-year survival among patients with hepatocellular carcinoma in the United States: an analysis of SEER-Medicare.
Zhang X; El-Serag HB; Thrift AP
Cancer Causes Control; 2021 Apr; 32(4):317-325. PubMed ID: 33394207
[TBL] [Abstract][Full Text] [Related]
17. Disparities in outcomes and access to therapy options in hepatocellular carcinoma.
Beltrán Ponce S; Gokun Y; Douglass F; Dawson L; Miller E; Thomas CR; Pitter K; Conteh L; Diaz DA
J Natl Cancer Inst; 2024 Feb; 116(2):264-274. PubMed ID: 37831897
[TBL] [Abstract][Full Text] [Related]
18. Trends in early-stage hepatocellular carcinoma, California 1988-2010.
Rodriguez DN; Torruellas C; Cress RD
Cancer Causes Control; 2016 Mar; 27(3):325-31. PubMed ID: 26662039
[TBL] [Abstract][Full Text] [Related]
19. Underlying Bias in the Treatment of Pancreatic Cancer: Minorities Treated at the Same Facilities are Less Likely to Receive Neoadjuvant Therapy.
Lopez-Verdugo F; Fong ZV; Lillemoe KD; Blaszkowsky LS; Parikh AR; Wo JY; Hong TS; Ferrone CR; Fernandez-Del Castillo C; Qadan M
Ann Surg; 2023 May; 277(5):829-834. PubMed ID: 34954756
[TBL] [Abstract][Full Text] [Related]
20. Who, where, when: Colorectal cancer disparities by race and ethnicity, subsite, and stage.
Primm KM; Malabay AJ; Curry T; Chang S
Cancer Med; 2023 Jul; 12(13):14767-14780. PubMed ID: 37212502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
